소오침탕가감방(小烏沈湯加減方)의 산화스트레스와 serotonin 대사 과정에 미치는 영향

Effects of So-Ochim-tang-Gagam-bang on Oxidative Stress and Serotonin Metabolism in P815 Cells

  • 황지연 (대전대학교 한의과대학 신경정신과학교실) ;
  • 이상룡 (대전대학교 한의과대학 신경정신과학교실) ;
  • 정인철 (대전대학교 한의과대학 신경정신과학교실)
  • Hwang, Ji-Yeon (Department of Neuropsychiatry, College of Korean Medicine, Daejeon University) ;
  • Lee, Sang Ryong (Department of Neuropsychiatry, College of Korean Medicine, Daejeon University) ;
  • Jung, In Chul (Department of Neuropsychiatry, College of Korean Medicine, Daejeon University)
  • 투고 : 2013.05.22
  • 심사 : 2013.07.03
  • 발행 : 2013.08.25

초록

This experiment was designed to investigate the effects of So-Oochim-tang-Gagam-bang (SOCT-G) on oxidative stress and serotonin metabolism in P815 Mast Cells The effects of SOCT-G on activity of 2,2-Diphenyl-1-picrylhydrazyl (DPPH) radical-scavenging and Super Oxide Dismutase (SOD) in P815 mast cells were investigated. The effect of SOCT-G on content of serotonin in P815 mast cells was investigated. The effects of SOCT-G on expression of 5-hydroxytryptamine transporter (5-HTT), Tryptophan hydroxylase 1 (TPH-1) mRNA in P815 mast cells were investigated. The SOCT-G increased DPPH radical-scavenging activity in P815 mast cells. The SOCT-G increased SOD activity in P815 mast cells. The SOCT-G decreased the intracellular content of serotonin in P815 mast cells. The SOCT-G decreased 5-HTT and TPH-1 mRNA expression in P815 mast cells. This experiment shows that So-Ochm-Tang-Gagam-bang has a significant effect of oxidative stress that help prevent free radical damage. And So-Ochim-Tang-Gagam-bang decreased the intracellular content of serotonin and mRNA expression of 5-HTT and TPH-1. Therefore, further researches are suggested to reveal the anti-depressive effectiveness of So-Ochim-Tang-Gagam-bang.

키워드

참고문헌

  1. Clarke, D.D., Sokoloff, L., edited by Siegel, G.J., Agranoff B.W., Albers, R.W., Fisher, S.K., Uhler, M.D. Circulation and energy metabolism of the brain. In Basic neurochemistry: Molecular, cellular and medical aspects. Philadelphia:PA Lippincott-Raven. pp 637-639, 1999.
  2. Adham, N., Borden, L.A., Schechte, L.E., Gustafson, E.L., Branchek, T.A. Cell-specific coupling of the cloned human 5-HTlF receptor to multiple signal transduction pathways. Naunyn-Schmiedeberg's Archives of Pharmacology. p 348; 566; 1993.
  3. Hoyer, D., Clarke, D.E., Fozard, J.R., Hartig, P.R., Martin, G.R., Mylecharrane, E.J., Saxena, P.R., Humprey, P.P.A. International union of pharmacology c1assification of reports for 5-hydroxytryptamine(serotonin). Pharmacological Reviews. p 46; 157; 1994.
  4. Sodhi, M.S., Sanders-Bush, E. Serotonin and brain development. International Review of Neurobiology. 59: 111-174, 2004. https://doi.org/10.1016/S0074-7742(04)59006-2
  5. Kim, S.J., Seok, J.H., Kim, C.H. Serotonin Transporter and Pharmacotherapy. The Korean journal of psychopharmacology. 17(3):263-272, 2006.
  6. Schindler, R., Day, M., Fisher, G.A. Culture of neoplastic mast cells and their synthesis of 5-hydroxytryptamine and histamine in vitro. Cancer Research. 19: 47-51, 1959.
  7. Chenshiwen. Taiping hui min he ji ju fang. Beijing:People's medical publishing house. p 87, 2007.
  8. Huh, J. Donguibogam. Gyeongnam:Donguibogam Publisher. pp 73-76; 79, 2005.
  9. The Textbook Compilation Committee of Neuropsychiatry of oriental medical schools in nation. The Neuropsychiatry of Oriental medicine. Seoul. Jipmoon-Dang. pp 256-265, 2007.
  10. Jung, I.C., Lee, S.R. The Antioxidant Effects of ONDAMTANG on the Brain Tissue of Mouse. Journal of Oriental Neuropsychiatry. 8(2):51-62, 1997.
  11. Lee, S.H., Lee, J.M., Cho, J.H., Lee, C.H., Jang, J.B., Lee, K.S. Antioxidant and Neuroprotective Effects of Gamisoyo-san. The Journal Of Oriental Gynecology. 23(3):1-13, 2010.
  12. Cho, C.H., Shin, H.K., Whang, W.W. Effects of Chengwhabosimtang on depression, anxiety, TH and c-Fos of the brain in the CMS treated rats. Korean journal of oriental medicine. 9(1):157-178, 2003.
  13. Park, S.W. Antidepressant Action of Kami-shoyosan. Department of medicine The Graduate School, Inje University. 2003.
  14. Park, J.H., Bae, C.W., Jun, H.S., Hong, S.Y., Park, S.D. The Korean journal of oriental medical prescription. The Korean journal of oriental medical prescription. 12(2):77-93, 2004.
  15. Shin, H.S., Kweon, Y.M., Park, S.D. Antidepressant effect of Sayuksan and its influence on monoamines of depression model rats. Korean journal of herbology. 19(2):71-82, 2004.
  16. Park, J.S., Lee, I., Jung, Y.G., Koo, B.S., Kim, G.W. Experimental Study on the Antidepressant Effect of Cheongsimondam-tang. Journal of Oriental Neuropsychiatry. 18(1):1-14, 2007.
  17. No, D.J., Jung, I.C. Study on Effect to Serotonin Metabolism of Gamiguibi-tang on P815 Cell. Journal of Oriental Neuropsychiatry. 21(1):1-11, 2010.
  18. Lim, J.W., Jung, I.C., Lee, S.R. The Effects of BunSimGiEumGami-Bang(Fenxinqiyinjiam eifang) on Serotonin of P815 cell. Journal of Oriental Neuropsychiatry. 22(2):147-162, 2011.
  19. Sim, T.K., Jung, I.C., Lee, S.R. The Effect of Gamisoyo-san( Jiaweixiaoyaosan) on Serotonin Metabolism. Journal of Oriental Neuropsychiatry. 22(1):37-51, 2011.
  20. Jitendra Yadav Nehete, Vitthal Nivrutti Deshmukh, Vikas Vasant Shewale, Minal Raghunath Narkhede, Vilas Murlidhar Aurangabadkar. In - vitro antioxidant activity of Achyranthes aspera L. Journal of Pharmacy Research. 2(9):1402-1403, 2009.
  21. Lowry, O.H., Rosebrough, N.J., Farr, A.L., Randall, R.J. Protein measurement with the folin phenol reagent. Journal of Biological Chemistry. 193: 265-275, 1951.
  22. Hwang, D.Y. Jeungmaek bangyakhappyeon. Seoul, Namsan-Dang. p 142, 2000.
  23. The Textbook Compilation Committee of Herbalogy of oriental medical schools in nation. Herbalogy. Seoul, Younglim-Sa. pp 395-400, 2007.
  24. The Textbook Compilation Committee of Herbalogy. Herbal pharmacology. Seoul, Shinilsangsa. pp 263-268; 610-613, 2005.
  25. Huh J. Donguibogam. Gyeongnam, Donguibogam Publisher. p 82, 2131, 2005.
  26. Cormer, L.E., Katon, W., Russo, J., Hollifield, M., Hall, M.L., Vitalian, P.P. Chest pain with negative cardiac diagnostic studies. Relationship to psychiatric illness. Journal of Nervous and Mental Disease. 176(6):351-358, 1988. https://doi.org/10.1097/00005053-198806000-00004
  27. Serlie, A.W., Erdman, R.a., Passchier, J., Trijsburg, R.W., ten Cate, F.J. Psychological aspects of non-cardiac chest pain. Psychotherapy and Psychosomatics. 64(2):62-73, 1995. https://doi.org/10.1159/000288993
  28. Park, J.E., Ryu, H.W., Rhee, P.L., Yu, B.H. GERD-unrelated Non-cardiac Chest Pain may be Associated with Depression and Anxiety. Anxiety and Mood. 2(1):28-32, 2006.
  29. Cho, H.J., Kim, S.H., Sonh, H.J. Medical consideration the east and west of the chest pain. Journal of the Institute of Oriental Medicine, Daejeon University. 6(2):313-327, 1998.
  30. Hwang, E.S., Kim, G.H. Biomarkers of oxidative stress status of DNA, lipids, and proteins in vitro and in vivo cancer research. Toxicology. 229(5):1-10, 2007. https://doi.org/10.1016/j.tox.2006.10.013
  31. Andreazza, A.C., Cassini, C., Rosa, A.R., Leite, M.C., de Almeida, L., Nardin, P., Cunha, A.B., Cereser, K.M., Santin, A., Gottfried, C., Salvador, M., Kapczinski, F., Goncalves, C.A. Serum S100B and antioxidant enzymes in bipolar patients. Journal of Psychiatric Research. 41(6):523-529, 2007. https://doi.org/10.1016/j.jpsychires.2006.07.013
  32. Andreazza, A.C., Kauer-Sant'anna, M., Frey, B.N., Bond, D.J., Kapczinski, F., Young, L.T., Yatham, L.N. Oxidative stress markers in bipolar disorder: A meta-analysis. Journal of Affective Disorders. 111(2-3):135-144, 2008. https://doi.org/10.1016/j.jad.2008.04.013
  33. Halliwell, B. Oxidative stress and neurodegeneration: where are we now. Journal of Neurochemistry. 97(6):1634-1658, 2006. https://doi.org/10.1111/j.1471-4159.2006.03907.x
  34. Oh, M.S., Kim, D.R., Kang, J.U. Study on Antioxidant Potency of Cuscutae Semen, Psoraleae Fructus, Cnidii Fructus and Epimedii Herba by DPPH Method. The Korean Journal of Oriental Medical Prescription. 12(2):101-110, 2005.
  35. Dubinina, E.E., Pustygina, A.V. Free radical processes in aging, neurodegenerative diseases and other pathological states. Biomed Khim. 53(4):351-372, 2007.
  36. Lyoyd, D. How to avoid oxygen. Science. 286(5438):249, 1999. https://doi.org/10.1126/science.286.5438.249
  37. Kim, H.C. Diagnosis and Assessment of Depression according to Biological Methods. Journal of the Korean Society of Biological Therapies in Psychiatry. 5(1):11-28, 1999.
  38. Kennedy, S.H., Lam, R.W., Cohen, N.L., Ravindran, A.V. Clinical guidelines for the treatment of depressive disorders. IV. Medications and other biological treatments. Canadian Journal of Psychiatry. 46(1):38S-58S, 2001.
  39. Thase, M.E. Overview of antidepressant therapy. Managed care. 10: 6-9, 2001.
  40. Meltzer, H.Y., Li, Z., Kaneda, Y., Ichikawa, J. Serotonin receptors: their key role in drugs to treat schizophrenia. Prog Neuropsychopharmacol Biol Psychiatry. 27: 1159-1172, 2003. https://doi.org/10.1016/j.pnpbp.2003.09.010
  41. Lovenberg, W., Bourgoin, S., Hery, F., Sjoerdsas, A. Tryptophan hydroxylation; measurement in pineal gland, brain stem and carcinoid tumor. Science. 155: 217-219, 1967. https://doi.org/10.1126/science.155.3759.217
  42. Carkaci-Salli, N., Flanagan, J.M., Martz, M.K., Salli, U., Walther, D.J., Bader, M., Vrana, K.E. Functional domains of human tryptophan hydroxylase 2 (hTPH2). Journal of Biological Chemistry. 281(38):28105-28112, 2006. https://doi.org/10.1074/jbc.M602817200
  43. Amara, S.G., Kuhar, M.J. Neurotransmitter trasporter: Recent progress. Annual Review of Neuroscience. 16: 73-93, 1993. https://doi.org/10.1146/annurev.ne.16.030193.000445
  44. Blakely, R.D., Felice, K., Hartzell, H. Molecular physiology of norepinephrine and serotonin transporters. The Journal of Experimental Biology. 196: 263-281, 1994.
  45. Ogilvie, A.D., Battersby, S., Bubb, V.J., Fink, G., Harmar, A.J., Goodwin, G.M., et al. Polymorphism in serotonin trasporter gene associated with susceptibility to major depression. Lancet. 347: 731-733, 1996. https://doi.org/10.1016/S0140-6736(96)90079-3
  46. Lee, M.K., Kim, E.I., Hur, J.D., Lee, K.S., Ro, J.S. Effects of Protoberberine Compounds on Serotonin Content in P815 Cells. Korean Journal of Pharmacognosy. 32(1):49-54, 2001.
  47. Wen-Huang Peng, Kuan-Lin Lo, Yi-Hsuen Lee, Tai-Huang Hung, Ying-Chin Lin. Berberine produces antidepressant-like effects in the forced swim test and in the tail suspension test in mice. Life Science. 81: 933-938, 2007. https://doi.org/10.1016/j.lfs.2007.08.003
  48. Kim, E.I., Shin, J.S., Lim, S.C., Park, S.K., Lee, M.K. Inhibitory Effects of Ethaverine on Serotonin Content in Murine Mastocytoma P815 Cells. Yakhak Hoeji. 51(2):83-87, 2007.
  49. Lee, S.K., Kim, S.H., Kim, R.U., Yoon, S.H., Kim, Y.G., Kim, G.T., Kim, Y.H. Antidepressant Effects of Ethaverine, a Calcium Channel Antagonist,in Animal Models of Depression. Jorunal of The Korean Neuropsychiatric Association. 39(2):445-455, 2000.
  50. Lee, S.K., Kim, S.H., Park, S.W., Yoon, S.H., Kim, S.J., Kim, Y.G., Seo, Y.H., Kim, G.T., Kim, Y.H. Antidepressant Effect of Ethaverine. The Korean journal of psychopharmacology. 12(1):49-63, 2001.
  51. Richardson-Jones, J.W., Craige, C.P., Guiard, B.P., Stephen, A., Metzger, K.L., Kung, H.F., Gardier, A.M., Dranovsky, A., David, D.J., Beck, S.G., Hen, R., Leonardo, E.D. 5-HT1A autoreceptor levels determine vulnerability to stress and response to antidepressants. Neuron. 65(1):40-52, 2010. https://doi.org/10.1016/j.neuron.2009.12.003
  52. Sampson, D., Wilner, P., Muscat, R. Reversal of antidepressant action by dopamine antagonists in an animal model of depression. Psychopharmacology(Berl). 104: 491-495, 1991. https://doi.org/10.1007/BF02245655
  53. Roy, A., Karoum, F., Pollack, S. Marked reduction in indexes of dopamine metabolism among patients with depression who attempts suicied. Archives of General Psychiatry. 49: 447-450, 1992. https://doi.org/10.1001/archpsyc.1992.01820060027004
  54. Yoon, S.H., Kim, J.H., Kim, Y.H. Effects of noradrenaline and dopamine system of medicine based improvement of antidepressants on the reduction of model time floating incarceration Rats. Neuro-Psychiatry. 35: 1476-1486, 1996.
  55. Vetulani, J., Antkiewicz, M.L., Rokosz, P.A., Pilc, A. Alpha up-beta down adreneric regulation: a possible mechanism of action of antidepressant treatments. Polish Journal of Pharmacology & Pharmacy. 36: 231-248, 1984.